Effect of insulin glargine and nph insulin on quality of life in patients with type 2 diabetes mellitus

被引：0

作者：

Gupta, K. S. ^{[1
]}

Gupta, U. ^{[1
]}

机构：

[1] Maulana Azad Med Coll, New Delhi, India

来源：

VALUE IN HEALTH | 2007年 / 10卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)68751-7

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A70 / A70

页数：1

共 50 条

[31] Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies
Duckworth, William
Davis, Stephen N.
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (03) : 196 - 204
[32] Lower severe hypoglycemia risk: Insulin glargine versus NPH insulin in type 2 diabetes
Dailey, George
Strange, Poul
AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (01): : 25 - 30
[33] The Influence of Insulin Degludec on Type 2 Diabetes Mellitus Regulation and Patient Quality of Life Compared with Insulin Glargine in Low-Income Patients
Koutsovasilis, Anastasios
Sotiropoulos, Alexios
Pappa, Maria
Bousboulas, Stavros
Peppas, Theodoros
DIABETES, 2020, 69
[34] Diabetic retinopathy in patients with type 1 diabetes treated with insulin glargine or NPH
Peters, K
Garg, SK
JAckson, WE
Mackenzie, T
Queen, J
Anil, S
Chase, HP
DIABETES, 2001, 50 : A443 - A443
[35] Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes
Ashwell, Simon G.
Bradley, Clare
Stephens, James W.
Witthaus, Elke
Home, Philip D.
DIABETES CARE, 2008, 31 (06) : 1112 - 1117
[36] Concomitant use of insulin glargine and NPH in type I diabetes
Khadilkar, VV
Khadilkar, AV
INDIAN PEDIATRICS, 2005, 42 (08) : 796 - 800
[37] Fasting blood glucose for insulin adjustment with insulin glargine or NPH insulin combined with sulphonylurea in Type 2 diabetes
Haupt, A
Eckert, H
Schweitzer, MA
Peiker, J
Häring, HU
Fritsche, A
DIABETOLOGIA, 2004, 47 : A269 - A269
[38] Evaluation of immunogenicity of LY2963016 insulin glargine compared with insulin glargine in patients with type 2 diabetes mellitus
Ilag, L. L.
Deeg, M. A.
Huster, W. J.
Costigan, T. M.
Zielonka, J. S.
Pollom, R. K.
Prince, M. J.
Konrad, R. J.
DIABETOLOGIA, 2014, 57 : S397 - S398
[39] Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain
Terrés, CR
Rodríguez, J
Bolinder, B
de Pablos, P
DIABETOLOGIA, 2004, 47 : A345 - A345
[40] Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain
Delgado, E.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (03) : 281 - 288

← 1 2 3 4 5 →